← Back to Search

Cecelia Health plus OneTouch Verio Reflect® BGM and OneTouch Reveal® mobile app for Type 2 Diabetes (ECLIPSE Trial)

N/A
Waitlist Available
Led By Jennifer Lee, PhD
Research Sponsored by LifeScan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial tests how well a special blood sugar meter and various health programs help people with type 2 diabetes manage their condition. Participants will use the meter and one of the health programs to track their blood sugar and improve their overall health.

Eligible Conditions
  • Type 2 Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups
Experimental Treatment
Group I: WelldocExperimental Treatment1 Intervention
Multi-condition support program from Welldoc subscription for 1 year. Subjects will also be provided with the OneTouch Verio Reflect glucose meter.
Group II: NoomExperimental Treatment1 Intervention
Noom behavioural weight loss program subscription for 1 year. Subjects will also be provided with the OneTouch Verio Reflect glucose meter and the OneTouch Reveal (OTR) mobile diabetes app.
Group III: FitbitExperimental Treatment1 Intervention
Fitbit Inspire 2 wearable plus 1 year subscription to premium Fitbit application. Subjects will also be provided with the OneTouch Verio Reflect glucose meter and the OneTouch Reveal (OTR) mobile diabetes app.
Group IV: Cecelia HealthExperimental Treatment1 Intervention
Access to live Cecelia health coach on the telephone for 1 year plus access to Cecelia health coach by text messaging (via the OneTouch Reveal mobile diabetes app). Subjects will be provided with the OneTouch Verio Reflect glucose meter and the OneTouch Reveal (OTR) diabetes app.

Find a Location

Who is running the clinical trial?

Evidation HealthIndustry Sponsor
19 Previous Clinical Trials
276,682 Total Patients Enrolled
LifeScanLead Sponsor
33 Previous Clinical Trials
18,859 Total Patients Enrolled
Jennifer Lee, PhDPrincipal InvestigatorEvidation Health
~246 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top